{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:28:10Z","timestamp":1793377690180,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Improvement Project for Theranostic Ability on Difficulty Miscellaneous Disease","award":["ZLYNXM202007"],"award-info":[{"award-number":["ZLYNXM202007"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171986"],"award-info":[{"award-number":["82171986"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00259-023-06369-z","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T04:02:06Z","timestamp":1690862526000},"page":"4064-4076","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["[68Ga]Ga-FAPI-04 PET\/CT in the evaluation of epithelial ovarian cancer: comparison with [18F]F-FDG PET\/CT"],"prefix":"10.1007","volume":"50","author":[{"given":"Jie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongjiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueli","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9846-7578","authenticated-orcid":false,"given":"Yong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"6369_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin."},{"key":"6369_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/IJWH.S197604","volume":"11","author":"Z Momenimovahed","year":"2019","unstructured":"Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019;11:287\u201399. https:\/\/doi.org\/10.2147\/IJWH.S197604.","journal-title":"Int J Womens Health."},{"key":"6369_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12957-018-1339-0","volume":"16","author":"A Llueca","year":"2018","unstructured":"Llueca A, Serra A, Rivadulla I, Gomez L, Escrig J. MUAPOS working group (Multidisciplinary Unit of Abdominal Pelvic Oncology Surgery). Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index. World J Surg Oncol. 2018;16:37. https:\/\/doi.org\/10.1186\/s12957-018-1339-0.","journal-title":"World J Surg Oncol."},{"key":"6369_CR4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010;177:1053\u201364. https:\/\/doi.org\/10.2353\/ajpath.2010.100105.","journal-title":"Am J Pathol."},{"key":"6369_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ygyno.2022.06.010","volume":"166","author":"C Keunecke","year":"2022","unstructured":"Keunecke C, Kulbe H, Dreher F, Taube ET, Chekerov R, Horst D, et al. Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancer. Gynecol Oncol. 2022;166:334\u201343. https:\/\/doi.org\/10.1016\/j.ygyno.2022.06.010.","journal-title":"Gynecol Oncol."},{"key":"6369_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejrad.2010.11.039","volume":"78","author":"N Bharwani","year":"2011","unstructured":"Bharwani N, Reznek RH, Rockall AG. Ovarian Cancer Management: the role of imaging and diagnostic challenges. Eur J Radiol. 2011;78:41\u201351. https:\/\/doi.org\/10.1016\/j.ejrad.2010.11.039.","journal-title":"Eur J Radiol."},{"key":"6369_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.diii.2018.11.007","volume":"100","author":"S Nougaret","year":"2019","unstructured":"Nougaret S, Tardieu M, Vargas HA, Reinhold C, Vande Perre S, Bonanno N, et al. Ovarian cancer: An update on imaging in the era of radiomics. Diagn Interv Imaging. 2019;100:647\u201355. https:\/\/doi.org\/10.1016\/j.diii.2018.11.007.","journal-title":"Diagn Interv Imaging."},{"key":"6369_CR8","doi-asserted-by":"publisher","unstructured":"Forstner R, Sala E, Kinkel K, Spencer JA; European Society of Urogenital Radiology. ESUR guidelines: ovarian cancer staging and follow-up. Eur Radiol. 2010; 20:2773-2780. https:\/\/doi.org\/10.1007\/s00330-010-1886-4.","DOI":"10.1007\/s00330-010-1886-4"},{"key":"6369_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1148\/radiology.215.3.r00jn25761","volume":"215","author":"CM Tempany","year":"2000","unstructured":"Tempany CM, Zou KH, Silverman SG, Brown DL, Kurtz AB, McNeil BJ. Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group. Radiol. 2000;215:761\u20137. https:\/\/doi.org\/10.1148\/radiology.215.3.r00jn25761.","journal-title":"Radiol."},{"key":"6369_CR10","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1007\/s00259-021-05450-9","volume":"48","author":"RC Delgado Bolton","year":"2021","unstructured":"Delgado Bolton RC, Aide N, Colletti PM, Ferrero A, Paez D, Skanjeti A, et al. EANM guideline on the role of 2-[18F]FDG PET\/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA). Eur J Nucl Med Mol Imaging. 2021;48:3286\u2013302. https:\/\/doi.org\/10.1007\/s00259-021-05450-9.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"6369_CR11","doi-asserted-by":"publisher","first-page":"CD012567","DOI":"10.1002\/14651858.CD012567.pub2","volume":"10","author":"JF Roze","year":"2018","unstructured":"Roze JF, Hoogendam JP, van de Wetering FT, Spijker R, Verleye L, Vlayen J, et al. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian\/fallopian tube\/primary peritoneal cancer. Cochrane Database Syst Rev. 2018;10:CD012567. https:\/\/doi.org\/10.1002\/14651858.CD012567.pub2.","journal-title":"Cochrane Database Syst Rev."},{"key":"6369_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/IGC.0000000000000074","volume":"24","author":"Y Tanizaki","year":"2014","unstructured":"Tanizaki Y, Kobayashi A, Shiro M, Ota N, Takano R, Mabuchi Y, et al. Diagnostic value of preoperative SUVmax on FDG-PET\/CT for the detection of ovarian cancer. Int J Gynecol Cancer. 2014;24:454\u201360. https:\/\/doi.org\/10.1097\/IGC.0000000000000074.","journal-title":"Int J Gynecol Cancer."},{"key":"6369_CR13","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1007\/s00330-022-09251-y","volume":"33","author":"C Li","year":"2023","unstructured":"Li C, Tian Y, Chen J, Jiang Y, Xue Z, Xing D, et al. Usefulness of [68Ga]FAPI-04 and [18F]FDG PET\/CT for the detection of primary tumour and metastatic lesions in gastrointestinal carcinoma: a comparative study. Eur Radiol. 2023;33:2779\u201391. https:\/\/doi.org\/10.1007\/s00330-022-09251-y.","journal-title":"Eur Radiol."},{"key":"6369_CR14","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1007\/s00259-021-05307-1","volume":"48","author":"FL Giesel","year":"2021","unstructured":"Giesel FL, Kratochwil C, Schlittenhardt J, Dendl K, Eiber M, Staudinger F, et al. Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET\/CT in cancer patients. Eur J Nucl Med Mol Imaging. 2021;48:4377\u201385. https:\/\/doi.org\/10.1007\/s00259-021-05307-1.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"6369_CR15","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","volume":"48","author":"K Dendl","year":"2021","unstructured":"Dendl K, Koerber SA, Finck R, Mokoala KMG, Staudinger F, Schillings L, et al. 68Ga-FAPI-PET\/CT in patients with various gynecological malignancies. Eur J Nucl Med Mol Imaging. 2021;48:4089\u2013100. https:\/\/doi.org\/10.1007\/s00259-021-05378-0.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"6369_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MNM.0000000000001653","volume":"44","author":"W Zheng","year":"2023","unstructured":"Zheng W, Liu L, Feng Y, Wang L, Chen Y. Comparison of 68Ga-FAPI-04 and fluorine-18-fluorodeoxyglucose PET\/computed tomography in the detection of ovarian malignancies. Nucl Med Commun. 2023;44:194\u2013203. https:\/\/doi.org\/10.1097\/MNM.0000000000001653.","journal-title":"Nucl Med Commun."},{"key":"6369_CR17","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00259-022-06096-x","volume":"50","author":"S Liu","year":"2023","unstructured":"Liu S, Feng Z, Xu X, Ge H, Ju X, Wu X, et al. Head-to-head comparison of [18F]-FDG and [68Ga]-DOTA-FAPI-04 PET\/CT for radiological evaluation of platinum-sensitive recurrent ovarian cancer. Eur J Nucl Med Mol Imaging. 2023;50:1521\u201331. https:\/\/doi.org\/10.1007\/s00259-022-06096-x.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"Suppl 6","key":"6369_CR18","doi-asserted-by":"publisher","first-page":"vi24","DOI":"10.1093\/annonc\/mdt333","volume":"24","author":"JA Ledermann","year":"2013","unstructured":"Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C, ESMO Guidelines Working Group. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi24\u201332. https:\/\/doi.org\/10.1093\/annonc\/mdt333.","journal-title":"Ann Oncol."},{"key":"6369_CR19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1148\/radiol.12120315","volume":"266","author":"E Sala","year":"2013","unstructured":"Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiol. 2013;266:717\u201340. https:\/\/doi.org\/10.1148\/radiol.12120315.","journal-title":"Radiol."},{"key":"6369_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/RLU.0b013e31826390ec","volume":"38","author":"HW Kim","year":"2013","unstructured":"Kim HW, Won KS, Zeon SK, Ahn BC, Gayed IW. Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET\/CT. Clin Nucl Med. 2013;38:93\u20137. https:\/\/doi.org\/10.1097\/RLU.0b013e31826390ec.","journal-title":"Clin Nucl Med."},{"key":"6369_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","volume":"124","author":"J Prat","year":"2014","unstructured":"Prat J, FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124:1\u20135. https:\/\/doi.org\/10.1016\/j.ijgo.2013.10.001.","journal-title":"Int J Gynaecol Obstet."},{"key":"6369_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s13402-020-00513-9","volume":"43","author":"M Yousefi","year":"2020","unstructured":"Yousefi M, Dehghani S, Nosrati R, Ghanei M, Salmaninejad A, Rajaie S, et al. Current insights into the metastasis of epithelial ovarian cancer-hopes and hurdles. Cell Oncol (Dordr). 2020;43:515\u201338. https:\/\/doi.org\/10.1007\/s13402-020-00513-9.","journal-title":"Cell Oncol (Dordr)."},{"key":"6369_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","volume":"133","author":"DG Mutch","year":"2014","unstructured":"Mutch DG, Prat J. 2014 FIGO Staging for Ovarian, Fallopian Tube and Peritoneal Cancer. Gynecol. Oncol. 2014;133:401\u20134. https:\/\/doi.org\/10.1016\/j.ygyno.2014.04.013.","journal-title":"Gynecol. Oncol."},{"key":"6369_CR24","doi-asserted-by":"publisher","first-page":"972","DOI":"10.6004\/jnccn.2022.0047","volume":"20","author":"DK Armstrong","year":"2022","unstructured":"Armstrong DK, Alvarez RD, Backes FJ, Bakkum-Gamez JN, Barroilhet L, Behbakht K, et al. NCCN Guidelines\u00ae Insights: Ovarian Cancer, Version 3.2022. J Natl Compr Canc Netw. 2022;20:972\u201380. https:\/\/doi.org\/10.6004\/jnccn.2022.0047.","journal-title":"J Natl Compr Canc Netw."},{"key":"6369_CR25","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00259-021-05522-w","volume":"49","author":"L Lan","year":"2022","unstructured":"Lan L, Liu H, Wang Y, Deng J, Peng D, Feng Y, et al. The potential utility of [68Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent-comparison with [18F]FDG. Eur J Nucl Med Mol Imaging. 2022;49:963\u201379. https:\/\/doi.org\/10.1007\/s00259-021-05522-w.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"6369_CR26","doi-asserted-by":"publisher","unstructured":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026.","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"6369_CR27","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/uog.23650","volume":"58","author":"F Moro","year":"2021","unstructured":"Moro F, Bertoldo V, Avesani G, Moruzzi MC, Mascilini F, Bolomini G, et al. Fusion imaging in preoperative assessment of extent of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings. Ultrasound Obstet Gynecol. 2021;58:916\u201325. https:\/\/doi.org\/10.1002\/uog.23650.","journal-title":"Ultrasound Obstet Gynecol."},{"key":"6369_CR28","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s11547-020-01170-6","volume":"125","author":"G Avesani","year":"2020","unstructured":"Avesani G, Arshad M, Lu H, Fotopoulou C, Cannone F, Melotti R, et al. Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival. Radiol Med. 2020;125:770\u20136. https:\/\/doi.org\/10.1007\/s11547-020-01170-6.","journal-title":"Radiol Med."},{"key":"6369_CR29","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1148\/rg.305105073","volume":"30","author":"S Kyriazi","year":"2010","unstructured":"Kyriazi S, Collins DJ, Morgan VA, Giles SL, deSouza NM. Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer. Radiographics. 2010;30:1269\u201385. https:\/\/doi.org\/10.1148\/rg.305105073.","journal-title":"Radiographics."},{"key":"6369_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/jso.20049","volume":"86","author":"E de Bree","year":"2004","unstructured":"de Bree E, Koops W, Kr\u00f6ger R, van Ruth S, Witkamp AJ, Zoetmulder FA. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol. 2004;86:64\u201373. https:\/\/doi.org\/10.1002\/jso.20049.","journal-title":"J Surg Oncol."},{"key":"6369_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/RLU.0000000000004057","volume":"47","author":"D Morland","year":"2022","unstructured":"Morland D, Jallerat P, Brixi H, Cadiot G, Papathanassiou D, Deguelte S. Performances of 18F-FDOPA PET\/CT in the Preoperative Evaluation of the Peritoneal Cancer Index in Small Intestine Neuroendocrine Tumors. Clin Nucl Med. 2022;47:294\u20138. https:\/\/doi.org\/10.1097\/RLU.0000000000004057.","journal-title":"Clin Nucl Med."},{"key":"6369_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1148\/radiol.2020203275","volume":"298","author":"Y Pang","year":"2021","unstructured":"Pang Y, Zhao L, Luo Z, Hao B, Wu H, Lin Q, et al. Comparison of 68Ga-FAPI and 18F-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers. Radiol. 2021;298:393\u2013402. https:\/\/doi.org\/10.1148\/radiol.2020203275.","journal-title":"Radiol."},{"key":"6369_CR33","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2214\/ajr.183.4.1831143","volume":"183","author":"N Pandit-Taskar","year":"2004","unstructured":"Pandit-Taskar N, Sch\u00f6der H, Gonen M, Larson SM, Yeung HW. Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET. AJR Am J Roentgenol. 2004;183:1143\u20137. https:\/\/doi.org\/10.2214\/ajr.183.4.1831143.","journal-title":"AJR Am J Roentgenol."},{"key":"6369_CR34","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1080\/0284186X.2020.1827157","volume":"59","author":"L Salminen","year":"2020","unstructured":"Salminen L, Gidwani K, Gr\u00e8nman S, Carp\u00e9n O, Hietanen S, Pettersson K, et al. HE4 in the evaluation of tumor load and prognostic stratification of high grade serous ovarian carcinoma. Acta Oncol. 2020;59:1461\u20138. https:\/\/doi.org\/10.1080\/0284186X.2020.1827157.","journal-title":"Acta Oncol."},{"key":"6369_CR35","doi-asserted-by":"publisher","first-page":"CD011964","DOI":"10.1002\/14651858.CD011964.pub2","volume":"7","author":"C Davenport","year":"2022","unstructured":"Davenport C, Rai N, Sharma P, Deeks JJ, Berhane S, Mallett S, et al. Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women. Cochrane Database Syst Rev. 2022;7:CD011964. https:\/\/doi.org\/10.1002\/14651858.CD011964.pub2.","journal-title":"Cochrane Database Syst Rev."},{"key":"6369_CR36","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ygyno.2007.01.028","volume":"105","author":"A Pereira","year":"2007","unstructured":"Pereira A, Magrina JF, Rey V, Cortes M, Magtibay PM. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer. Gynecol Oncol. 2007;105:604\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2007.01.028.","journal-title":"Gynecol Oncol."},{"key":"6369_CR37","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s12885-020-07144-1","volume":"20","author":"C Fang","year":"2020","unstructured":"Fang C, Zhang Y, Zhao L, Chen X, Xia L, Zhang P. The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients. BMC Cancer. 2020;20:654. https:\/\/doi.org\/10.1186\/s12885-020-07144-1.","journal-title":"BMC Cancer."},{"key":"6369_CR38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/uog.23654","volume":"59","author":"D Fischerova","year":"2022","unstructured":"Fischerova D, Pinto P, Burgetova A, Masek M, Slama J, Kocian R, et al. Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole-body diffusion-weighted MRI (ISAAC study). Ultrasound Obstet Gynecol. 2022;59:248\u201362. https:\/\/doi.org\/10.1002\/uog.23654.","journal-title":"Ultrasound Obstet Gynecol."},{"key":"6369_CR39","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3390\/diagnostics11101748","volume":"11","author":"C Mimoun","year":"2021","unstructured":"Mimoun C, Rouzier R, Benifla JL, Fauconnier A, Huchon C. Preoperative CT or PET\/CT to Assess Pelvic and Para-Aortic Lymph Node Status in Epithelial Ovarian Cancer? A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2021;11:1748. https:\/\/doi.org\/10.3390\/diagnostics11101748.","journal-title":"Diagnostics (Basel)."},{"key":"6369_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40644-019-0215-7","volume":"19","author":"M Laasik","year":"2019","unstructured":"Laasik M, Kemppainen J, Auranen A, Hietanen S, Gr\u00e9nman S, Sepp\u00e4nen M, et al. Behavior of FDG-avid supradiaphragmatic lymph nodes in PET\/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study. Cancer Imaging. 2019;19:27. https:\/\/doi.org\/10.1186\/s40644-019-0215-7.","journal-title":"Cancer Imaging."},{"key":"6369_CR41","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1245\/s10434-017-6051-8","volume":"24","author":"S Nasser","year":"2017","unstructured":"Nasser S, Kyrgiou M, Krell J, Haidopoulos D, Bristow R, Fotopoulou C. A Review of Thoracic and Mediastinal Cytoreductive Techniques in Advanced Ovarian Cancer: Extending the Boundaries. Ann Surg Oncol. 2017;24:3700\u20135. https:\/\/doi.org\/10.1245\/s10434-017-6051-8.","journal-title":"Ann Surg Oncol."},{"key":"6369_CR42","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1007\/s12094-022-02832-9","volume":"24","author":"M Polack","year":"2022","unstructured":"Polack M, Hagenaars SC, Couwenberg A, Kool W, Tollenaar RAEM, Vogel WV, et al. Characteristics of tumour stroma in regional lymph node metastases in colorectal cancer patients: a theoretical framework for future diagnostic imaging with FAPI PET\/CT. Clin Transl Oncol. 2022;24:1776\u201384. https:\/\/doi.org\/10.1007\/s12094-022-02832-9.","journal-title":"Clin Transl Oncol."}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06369-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06369-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06369-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T03:24:21Z","timestamp":1698463461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06369-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":42,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["6369"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06369-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]},"assertion":[{"value":"15 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any experiments with animals. All procedures involving human participants were carried out following the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors affirm that human research participants provided informed consent for the publication of the images in all figures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}